By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Affymetrix's stock rose as much as 13 percent today following the announcement on Wednesday that a new president and CEO would be leading the company starting July 1.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.